Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51.

Dirix PR, Mercier C, Dirix LY.

Eur Urol. 2019 Jun 26. pii: S0302-2838(19)30507-X. doi: 10.1016/j.eururo.2019.06.022. [Epub ahead of print] No abstract available.

PMID:
31255421
2.

Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51.

Hölscher T, Lohaus F, Wirth M, Troost EGC.

Eur Urol. 2019 Jun 27. pii: S0302-2838(19)30506-8. doi: 10.1016/j.eururo.2019.06.021. [Epub ahead of print] No abstract available.

PMID:
31256943
4.

Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83.

Fanti S, Krause B, Weber W, Castellucci P, Grosu AL, de Jong IJ, Messa C, Picchio M, Pruim J, Langsteger W, Chiti A; European Association of Nuclear Medicine (EANM).

Eur Urol. 2011 Nov;60(5):e37-8; author reply e39-41. doi: 10.1016/j.eururo.2011.08.009. Epub 2011 Aug 16. No abstract available.

PMID:
21855205
5.

Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93.

Rocco B, Sighinolfi MC.

Eur Urol. 2019 May 29. pii: S0302-2838(19)30437-3. doi: 10.1016/j.eururo.2019.05.030. [Epub ahead of print] No abstract available.

PMID:
31151677
6.

Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285-93.

von Eyben FE, Bauman G.

Eur Urol. 2019 Jul 9. pii: S0302-2838(19)30516-0. doi: 10.1016/j.eururo.2019.06.026. [Epub ahead of print] No abstract available.

PMID:
31300234
9.
10.
12.

Re: Kim N. Chi, Anders Bjartell, David Dearnaley, et al. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets. Eur Urol 2009;56:594-605.

Friedman AE.

Eur Urol. 2010 Feb;57(2):e16; author reply e17. doi: 10.1016/j.eururo.2009.11.006. Epub 2009 Nov 10. No abstract available.

PMID:
19914774
14.
17.

Re: Himisha Beltran, Tomasz M. Beer, Michael A. Carducci, et al. New therapies for castration-resistant prostate cancer: efficacy and safety. Eur urol 2011;60:279-90.

Braillon A.

Eur Urol. 2011 Oct;60(4):e33. doi: 10.1016/j.eururo.2011.06.054. Epub 2011 Jul 13. No abstract available.

PMID:
21767907

Supplemental Content

Support Center